Corsicana & Co’s Avidity Biosciences RNAM Stock Holding History

Corsicana & Co’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,000	Closed	-$236K	–	329
2026 Q1	$236K	Hold	8,000	–	–	0.15%	75
2025 Q4	$577K	Hold	8,000	–	–	0.32%	59
2025 Q3	$349K	Buy	+8,000	New	+$323K	0.2%	67

Corsicana & Co's RNAM Position: Q2 2026 in Review

Corsicana & Co sold out of Avidity Biosciences (RNAM) in Q2 2026, closing a stake of 8,000 shares — an estimated $236K sold.

Corsicana & Co first reported a position in RNAM in Q3 2025 and held it in 3 quarters. The position peaked at $577K in Q4 2025. 0 funds tracked by Wall St. Rank hold RNAM as of Q2 2026.

Corsicana & Co reported no remaining Avidity Biosciences position as of Q2 2026 after selling out during the quarter.
Corsicana & Co sold 8,000 Avidity Biosciences shares in Q2 2026, an estimated $236K.
Corsicana & Co first reported a position in Avidity Biosciences in Q3 2025 and held it in 3 quarters.
Corsicana & Co's Avidity Biosciences position peaked at $577K in Q4 2025.
0 funds tracked by Wall St. Rank held Avidity Biosciences as of Q2 2026.

Based on Corsicana & Co's 13F filing for Q2 2026, filed 24 Jul 2026.